- Hypertension:
- 1 tab OD
- Initially 5mg/160mg OD
- May increase dose after 1-2 weeks
- Max: 10mg/320mg/day
- 1 tab OD
- Tablet:
- 160mg/10mg
- 160mg/5mg
- 80mg/5mg
None remarkable
Amlodipine: Calcium channel blocker
Valsartan: Angiotensin II receptor blocker
- Peripheral edema
- Nasopharyngitis
- URI symptoms
- Dizziness
- Elevated Cr
- Increases ALT or AST
- Eczematous eruptions (chronic use in elderly patients)
- Hypersensitivity to class/components
- Pregnancy
WARNING
- Fetal/neonatal morbidity/mortality may occur when drugs that act directly on the renin-angiotensin system are used in pregnancy
- Aliskiren
- Cisapride
- Isocarboxazid
Drug Status
| Availability | Prescription only |
| Pregnancy | Category D |
| Breastfeeding | Contraindicated |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Avsar | 160mg/10mg | Tablet | 14’s | Pharmevo | Harley’s Ltd |
| Avsar | 80mg/5mg | Tablet | 14’s | Pharmevo | Harley’s Ltd |
| Avsar | 160mg/5mg | Tablet | 14’s | Pharmevo | Harley’s Ltd |
| Exforge | 5mg/160mg | Tablet | 28’s | Novartis | NVS Kenya |
| Exforge | 10mg/160mg | Tablet | 28’s | Novartis | NVS Kenya |
| Starva AM | 10mg/160mg | Tablet | 28’s | Sun Pharma | Sun Pharma |